161 related articles for article (PubMed ID: 30957125)
1. Transcriptomics-based validation of the relatedness of heterogeneous nuclear ribonucleoproteins to chronic lymphocytic leukemia as potential biomarkers of the disease aggressiveness.
Alsagaby SA
Saudi Med J; 2019 Apr; 40(4):328-338. PubMed ID: 30957125
[TBL] [Abstract][Full Text] [Related]
2. HELQ and EGR3 expression correlate with IGHV mutation status and prognosis in chronic lymphocytic leukemia.
Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
J Transl Med; 2021 Jan; 19(1):42. PubMed ID: 33485349
[TBL] [Abstract][Full Text] [Related]
3. Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia.
Liang T; Wang X; Liu Y; Ai H; Wang Q; Wang X; Wei X; Song Y; Yin Q
Front Immunol; 2022; 13():985280. PubMed ID: 36211334
[TBL] [Abstract][Full Text] [Related]
4. Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens.
Liao W; Jordaan G; Nham P; Phan RT; Pelegrini M; Sharma S
BMC Cancer; 2015 Oct; 15():714. PubMed ID: 26474785
[TBL] [Abstract][Full Text] [Related]
5. Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.
Li H; Yi SH; Xiong WJ; Liu HM; Lyu R; Wang TY; Liu W; Zhong SZ; Yu Z; Zou DH; Xu Y; An G; Li ZJ; Qiu LG
Chin Med J (Engl); 2017 Jan; 130(2):135-142. PubMed ID: 28091403
[TBL] [Abstract][Full Text] [Related]
6. The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome.
Brieghel C; da Cunha-Bang C; Yde CW; Schmidt AY; Kinalis S; Nadeu F; Andersen MA; Jacobsen LO; Andersen MK; Pedersen LB; Delgado J; Baumann T; Mattsson M; Mansouri L; Rosenquist R; Campo E; Nielsen FC; Niemann CU
Clin Cancer Res; 2020 Mar; 26(6):1507-1515. PubMed ID: 31919133
[TBL] [Abstract][Full Text] [Related]
7. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
8. Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia.
Pan B; Li Y; Xu Z; Miao Y; Yin H; Kong Y; Zhang X; Liang J; Xia Y; Wang L; Li J; Wu J; Xu W
Front Immunol; 2022; 13():962000. PubMed ID: 36275721
[TBL] [Abstract][Full Text] [Related]
9. hTERT expression and prognosis in B-chronic lymphocytic leukemia.
Tchirkov A; Chaleteix C; Magnac C; Vasconcelos Y; Davi F; Michel A; Kwiatkowski F; Tournilhac O; Dighiero G; Travade P
Ann Oncol; 2004 Oct; 15(10):1476-80. PubMed ID: 15367406
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
[TBL] [Abstract][Full Text] [Related]
11. lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome.
Ronchetti D; Manzoni M; Agnelli L; Vinci C; Fabris S; Cutrona G; Matis S; Colombo M; Galletti S; Taiana E; Recchia AG; Bossio S; Gentile M; Musolino C; Di Raimondo F; Grilli A; Bicciato S; Cortelezzi A; Tassone P; Morabito F; Ferrarini M; Neri A
Blood Cancer J; 2016 Sep; 6(9):e468. PubMed ID: 27611921
[TBL] [Abstract][Full Text] [Related]
12. Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia.
Giacopelli B; Zhao Q; Ruppert AS; Agyeman A; Weigel C; Wu YZ; Gerber MM; Rabe KG; Larson MC; Lu J; Blachly JS; Rogers KA; Wierda WG; Brown JR; Rai KR; Keating M; Rassenti LZ; Kipps TJ; Zenz T; Shanafelt TD; Kay NE; Abruzzo LV; Coombes KR; Woyach JA; Byrd JC; Oakes CC
Blood; 2019 Aug; 134(8):688-698. PubMed ID: 31292113
[TBL] [Abstract][Full Text] [Related]
13. The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index.
Muñoz-Novas C; Poza-Santaella M; González-Gascón Y Marín I; Hernández-Sánchez M; Rodríguez-Vicente AE; Infante MS; Heras C; Foncillas MÁ; Marín K; Hernández-Rivas JM; Hernández JÁ
Biomed Res Int; 2018; 2018():9506979. PubMed ID: 29736400
[TBL] [Abstract][Full Text] [Related]
14. Investigation of fatty acid metabolism in chronic lymphocytic leukemia to guide clinical outcome and therapy.
Pan B; Xu Z; Du K; Gao R; Zhang J; Yin H; Shen H; Liang J; Li Y; Wang L; Li J; Xu W; Wu J
Ann Hematol; 2024 Apr; 103(4):1241-1254. PubMed ID: 38150112
[TBL] [Abstract][Full Text] [Related]
15. Identification of key candidate genes and miRNA‑mRNA target pairs in chronic lymphocytic leukemia by integrated bioinformatics analysis.
Gao C; Zhou C; Zhuang J; Liu L; Wei J; Liu C; Li H; Sun C
Mol Med Rep; 2019 Jan; 19(1):362-374. PubMed ID: 30431072
[TBL] [Abstract][Full Text] [Related]
16. AKAP12 and IGFBP4 Are Prognostic Factors for Chronic Lymphocytic Leukemia.
Shi Y; Xu X; He Z; Tao H; Chen Y; Zhang L; Tao S; Ding B; Wang C; Yu L
Acta Haematol; 2023; 146(6):473-480. PubMed ID: 37605556
[TBL] [Abstract][Full Text] [Related]
17. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia.
Buhl AM; Jurlander J; Geisler CH; Pedersen LB; Andersen MK; Josefsson P; Petersen JH; Leffers H
Eur J Haematol; 2006 Jun; 76(6):455-64. PubMed ID: 16529606
[TBL] [Abstract][Full Text] [Related]
18. Exploring the nature of prediagnostic blood transcriptome markers of chronic lymphocytic leukemia by assessing their overlap with the transcriptome at the clinical stage.
Vlaanderen J; Leenders M; Chadeau-Hyam M; Portengen L; Kyrtopoulos SA; Bergdahl IA; Johansson AS; Hebels DD; de Kok TM; Vineis P; Vermeulen RC
BMC Genomics; 2017 Mar; 18(1):239. PubMed ID: 28320322
[TBL] [Abstract][Full Text] [Related]
19. Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance.
Van Damme M; Crompot E; Meuleman N; Maerevoet M; Mineur P; Bron D; Lagneaux L; Stamatopoulos B
Clin Epigenetics; 2016; 8():132. PubMed ID: 27980696
[TBL] [Abstract][Full Text] [Related]
20. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.
Kontos CK; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A
Clin Chem Lab Med; 2016 Feb; 54(2):315-24. PubMed ID: 26351937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
